Dr Chan Whiting | Director, Immune Monitoring and Biomarker Development
Aduro Biotech

Dr Chan Whiting, Director, Immune Monitoring and Biomarker Development, Aduro Biotech

Immunologist and scientific leader with over 15 years of experience in academia and biotechnology industry, specializing in the molecular basis of immune disorders, healthy aging and immunotherapeutics against cancers. Currently overseeing immune monitoring and biomarker development activities toward clinical trials using immunotherapies against a variety of cancers.

back to speakers